PNC FINANCIAL SERVICES GROUP, INC. - NOVOCURE LTD ownership

NOVOCURE LTD's ticker is NVCR and the CUSIP is G6674U108. A total of 292 filers reported holding NOVOCURE LTD in Q1 2023. The put-call ratio across all filers is 0.47 and the average weighting 0.1%.

Quarter-by-quarter ownership
PNC FINANCIAL SERVICES GROUP, INC. ownership history of NOVOCURE LTD
ValueSharesWeighting
Q3 2023$89,182
-47.1%
5,522
+36.0%
0.00%
Q2 2023$168,533
-32.1%
4,061
-1.6%
0.00%
Q1 2023$248,198
-17.9%
4,127
+0.1%
0.00%
Q4 2022$302,276
-3.7%
4,121
-0.1%
0.00%
Q3 2022$314,000
+11.0%
4,127
+1.0%
0.00%
Q2 2022$283,000
-32.8%
4,086
-19.6%
0.00%
Q1 2022$421,000
-20.1%
5,080
-27.5%
0.00%
Q4 2021$527,000
-22.5%
7,011
+19.9%
0.00%
-100.0%
Q3 2021$680,000
-71.7%
5,849
-46.1%
0.00%
-50.0%
Q2 2021$2,405,000
+77.8%
10,843
+5.9%
0.00%
+100.0%
Q1 2021$1,353,000
-24.4%
10,241
-1.0%
0.00%
-50.0%
Q4 2020$1,790,000
+56.3%
10,349
+0.6%
0.00%
+100.0%
Q3 2020$1,145,000
+54.1%
10,291
-17.8%
0.00%0.0%
Q2 2020$743,000
+7330.0%
12,516
+7771.7%
0.00%
Q1 2020$10,000
-73.0%
159
-64.3%
0.00%
Q4 2019$37,000
-96.2%
445
-96.5%
0.00%
-100.0%
Q3 2019$963,000
-27.4%
12,886
-38.6%
0.00%0.0%
Q2 2019$1,326,000
+563.0%
20,976
+405.4%
0.00%
Q1 2019$200,000
-31.0%
4,150
-52.1%
0.00%
Q4 2018$290,000
+64.8%
8,670
+158.0%
0.00%
Q3 2018$176,000
-22.8%
3,361
-53.8%
0.00%
Q2 2018$228,000
+70.1%
7,280
+17.8%
0.00%
Q1 2018$134,000
+24.1%
6,180
+14.9%
0.00%
Q4 2017$108,000
+1700.0%
5,380
+572.5%
0.00%
Q3 2016$6,000
-40.0%
8000.0%0.00%
Q2 2016$10,000
-16.7%
8000.0%0.00%
Q1 2016$12,000
-45.5%
800
-20.0%
0.00%
Q4 2015$22,0001,0000.00%
Other shareholders
NOVOCURE LTD shareholders Q1 2023
NameSharesValueWeighting ↓
Invus Financial Advisors, LLC 350,884$26,344,0008.01%
HARTLINE INVESTMENT CORP/ 318,109$23,884,0003.27%
Deep Track Capital, LP 550,000$41,294,0002.92%
MORGAN JESS S & CO INC 43,975$3,302,0002.03%
Taylor Frigon Capital Management LLC 46,376$3,482,0001.09%
Darsana Capital Partners LP 258,937$19,441,0000.90%
Private Harbour Investment Management & Counsel, LLC 13,562$1,018,0000.81%
Rhenman & Partners Asset Management AB 120,387$9,610,0000.64%
COURAGE CAPITAL MANAGEMENT LLC 10,000$751,0000.50%
Baillie Gifford 9,615,168$721,906,0000.40%
View complete list of NOVOCURE LTD shareholders